Showing results (201-210 of 216) with videos related to
Sort By:
Pageof 22
Wellcome Open Research|August 16, 2021
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER ProjectAura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, et al.Frontiers in Pharmacology|December 19, 2019
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method StudyEline van Overbeeke, Rosanne Janssens, Chiara Whichello, et al.Frontiers in Pharmacology|October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the USChiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.Journal of Market Access & Health Policy|March 28, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and CollaboratorsThomas Desmet, Elaine Julian, Walter Van Dyck, et al.International Journal of Technology Assessment in Health Care|June 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working GroupMilou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen, et al.The Lancet. Oncology|May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of CancerFábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.Frontiers in Psychology|July 10, 2023
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternativesSerena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, et al.BMC Health Services Research|July 13, 2021
Patients perspectives on drug shortages in six European hospital settings - a cross sectional studyDarija Kuruc Poje, Domagoj Kifer, Isabelle Huys, et al.Journal of Market Access & Health Policy|June 7, 2023
The role of stakeholder involvement in the evolving EU HTA process:Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, et al.Viruses|April 6, 2018
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production StrainsChristine Rohde, Grégory Resch, Jean-Paul Pirnay, et al.Pageof 22